期刊名称：GENOMICS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The goal of Genomics is the promotion of all facets of human and mouse genetic analysis. The scope of the journal is broad, and studies of other species that provide important insights into gene function in human and mouse will be considered.
The editors welcome original, full-length, comprehensive, and timely papers that represent significant advances in our under- standing of how genes function in normal and/or disease states. Papers in the areas of functional genomics, identification of genes involved in disease and complex traits, novel gene discovery, higher order genome organization, chromosome struc- ture, and functional genetic bases for human diversity are suitable. Manuscripts describing new technologies and methods and application of gene and genome analysis, including robotic and high-throughput strategies, are encouraged. The editors also encourage submission of manuscripts describing transgenic and gene modification mouse models, especially as they apply to human disease.
Instructions to Authors
The goal of Genomics is the promotion of all facets of human and mouse genetic analysis. The scope of the journal is broad, and studies of other species that provide important insights into gene function in human and mouse will be considered. The editor welcomes original, full-length, comprehensive, and timely papers that represent significant advances in our understanding of how genes function in normal and/or disease states. Papers in the areas of functional genomics, identification of genes involved in disease and complex traits, novel gene discovery, higher order genome organization, chromosome structure, and functional genetic bases for human diversity are suitable. Submission of manuscripts describing new technologies and methods and application of gene and genome analysis, including robotic and high-throughput strategies, is encouraged. The editor also encourages submission of manuscripts describing transgenic and gene modification mouse models, especially as they apply to human disease.
Manuscripts are accepted for review with the understanding that no substantial portion of the study has been published nor is under consideration for publication elsewhere, and that its submission for publication has been approved by all of the authors and by the institution where the work was carried out. Manuscripts that do not meet the general criteria or standards for publication in Genomics will be immediately returned to the authors, without detailed review.
Submission of manuscripts
Manuscripts must be written in English. There are no submission fees or page charges. Each manuscript should be accompanied by a letter outlining the basic findings of the paper and their significance. Authors should suggest an appropriate associate editor (see list of names at http://www.elsevier.com/locate/ygeno) and possible reviewers (up to five) in their field.
Authors are required to transmit the text and art of the manuscript via the Web site http://geno.edmgr.com. Instructions for uploading files are available on the site. If authors are unable to submit online, the manuscript may be sent in one of the following forms, along with a specific note of explanation of why it is not being transmitted via the Web site. Note: Revised versions of papers that were submitted before March 12, 2003, should be sent by e-mail, not uploaded to the Web site. Questions may be directed to the Editorial Office: genomics@elsevier.com; telephone (619) 699-6750; fax (619) 699-6700.
Postal mail: Manuscripts on floppy disk, Zip disk, or CD-ROM should be sent to:
Genomics
Editorial Office
525 B Street, Suite 1900
San Diego, CA 92101-4495, USA
Hard-copy printouts of the manuscript and art that exactly match the electronic file must be supplied.
E-mail (genomics@elsevier.com): Submission as an e-mail attachment is acceptable provided that all files are included in a single archive the size of which does not exceed 2 megabytes.
FTP (ftp.elsevier.com): An e-mail notifying the Editorial Office of any FTP submissions should be sent (along with an explanation of why the manuscript files were not uploaded via the Web site). Authors may access the site through their preferred FTP software. Log in with the username anon and password essd4acc. Place files in the "ygeno" folder.
Copyright
Authors submitting a manuscript do so on the understanding that if it is accepted for publication, copyright in the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the Publisher. The Copyright Transfer Agreement should be signed by the appropriate person.
Authors are responsible for obtaining permissions to reprint previously published figures, tables, and other material.
Genomics publishes the following:
- Articles. Organization should be Abstract, Introduction, Results, Discussion, Materials and methods, Acknowledgments, and References. There is a limit of 8 display items (figures plus tables) and 50 references. Manuscripts should be no more than 8 published pages. Accepted papers that are over 8 pages may be returned to the authors for additional editing. Manuscript length can be estimated by the total number of characters (spaces included), not the number of typed pages. The average number of characters per published page is approximately 7000. Count each table or figure as 2450 characters and add to the character count of your manuscript text. In other words, a regular submission should have no more than 56,000 characters (that is, 8 published pages).
The manuscript lenght can be estimated by the total number of characters (spaces included), not the number of typed pages. The average number of characters per published page is approximately 7000. Count each tavle or figure as 2450 characters and add to the character count of your manuscript text. In other words, a regular submission should have no more than 56,000 characters (that is, 8 published pages).
- Short communications. This section is open to succinct reports of important findings. They must not exceed 3 printed pages (6 double-spaced typewritten pages, including references and figure legends). Do not use any section headings except Acknowledgments and References. All short communications must have an abstract. Illustrative material should be kept to a minimum (not more than 2 tables or figures). References are limited to 30.
- Minireviews. The journal encourages the submission of concise, highly focused review articles summarizing recent progress in very active areas of research involving the analysis of genomes. Authors wishing to prepare such reviews should submit a short proposal, including an expected date of submission, to the editor.
- Special features. In addition to minireviews, special reviews of research programs for mapping and sequencing, historical sketches, genomics news, etc., are published periodically.
Preparation of manuscripts
Manuscripts submitted as hard copies should be double-spaced throughout on one side of 8.5 x 11-inch or A4 white paper. Pages should be numbered consecutively, and organized as follows:
- The title page (p. 1) should contain the article title (20 words or less), authors' names and complete affilitations, and the address for manuscript correspondence (including e-mail address and telephone and fax numbers). Affiliations should be footnoted using superscripted, lowercase Arabic letters (e.g., a, b, c, etc.).
- The Abstract (p. 2) must be a single paragraph that summarizes the main findings of the paper in less than 150 words. After the abstract a list of up to 10 keywords that will be useful for indexing or searching should be included (please use MeSH terminology; see http://www.nlm.nih.gov/mesh/meshhome.html). The Abstract should not be referenced.
- The Introduction should be as concise as possible, without subheadings.
- Results and Discussion may be combined and may be organized into subheadings.
- Materials and methods should be sufficiently detailed to enable the experiments to be reproduced. Names of manufacturers and their locations should be provided in parentheses.
- Acknowledgments should be brief and should precede the references. Individuals should be referred to by their full first name and surname, with their affilitation in parentheses. Titles (Dr., Professor, Mrs., etc.) are not permitted.
References should be cited in the text in numerical order (1, 2, 3,..., n). Reference numbers should be enclosed in brackets (for example, "Jones and colleagues [3] found that...") and should precede figure callouts. Arrange the reference list in numerical order as the references occur in the text, followed by those in the figure legends and tables. For references with 6 or more authors, please list only the first author followed by et al. Only articles that have been published or are in press should be included in the references. Unpublished results or personal communications should be cited as such in the text. Personal communications must include the date and the affiliation of the person communicating the material. Submitted manuscripts should not be cited in the reference list, but instead inserted in the text as follows: (J. Smith and R. Davis, manuscript submitted). The names of journals should be abbreviated according to the most recent edition of the List of Journals Indexed in Index Medicus (http://www.nlm.nih.gov/tsd/serials/lji.html). Please note the following examples.
(Book)
[1] N. Hagag, M.V. Viola, Chromosome Microdissection and Cloning: A Practical Guide, Academic Press, San Diego, 1993.
(Book Chapter)
[2] U. Reichert, S. Michel, R. Schmidt, The cornified envelope: a key structure of terminally differentiating keratinocytes, in: M. Darmon and M. Blumenberg (Eds.), Molecular Biology of the Skin: The Keratinocyte, Academic Press, San Diego, 1993, pp. 107-150.
(Journal)
[3] M.A. Curran, S.M. Kaiser, P.L. Achacoso, G.P. Nolan, Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors, Mol. Ther. 1 (2000) 31-38.
Nomenclature, abbreviations, and symbols. Authors must use approved nomenclature for all genes. Please obtain approved gene symbols before submission. Copies of correspondence documenting the approval of any new gene symbols should accompany all submissions. All unapproved symbols must be replaced with approved symbols (throughout the text and figures). Approved human gene symbols may be obtained before submission from Sue Povey (Nomenclature Editor, HUGO Gene Nomenclature Committee), Department of Biology, UCL, Wolfson House, 4 Stephenson Way, London NW1 2HE, UK; telephone: 44 20 7679 7410; fax: 44 20 7679 3496; e-mail: nome@galton.ucl.ac.uk; http://www.gene.ucl.ac.uk/nomenclature/. Approved mouse nomenclature may be obtained before submission from L. J. Maltais, The Jackson Laboratory, Bar Harbor, ME 04609-0800, USA; telephone: (207) 288-6429; fax: (207) 288-6132; e-mail: ljm@informatics.jax.org; http://www.informatics.jax.org/nomen/. In mouse, mutant strains and transgenic alleles also require approved symbols; see http://www.informatics.jax.org/. Use of unapproved gene symbols will likely delay publication.
Human and mouse protein symbols should be denoted in all capital letters (for example, FGF8). Use of "h" and "m" prefixes to distinguish between human and mouse proteins is not permitted. Instead, "mouse" or "human" should be inserted before the relevant protein symbol in cases where it is necessary to distinguish between human and mouse proteins. (This protocol extends to proteins of all other oganisms.)
Authors must use SI units and follow the guidelines for abbreviations and symbols of the IUPAC-IUBMB Joint Commission on Biochemical Nomenclature (http://www.chem.qmw.ac.uk/iupac/jcbn/).
GenBank/DNA sequence linking. Authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources should type this information in the following manner:
For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalized (see Example 1 below). This combination of letters and format will enable Elsevier's typesetters to recognize the relevant texts as accession numbers and add the required link to GenBank's sequences.
Example 1: GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117).
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link.
In the final version of the printed article, the accession number text will not appear bold or underlined (see Example 2 below).
Example 2: GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117).
In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases, enabling readers to go directly to that source from the article (see Example 3 below).
Example 3: GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117).
Figures. In the interest of quality and accuracy, we prefer to use author-supplied electronic artwork for all figures and complex tables. Each individual figure or graphic must be supplied as a separate, stand-alone file. Figure and table files must be named with their respective numbers and graphic types such as SmithFig1.tif, SmithFig2a.tif, SmithTable1.eps, etc. Long file names are acceptable.
Use EPS or TIFF file formats; TIFF is preferred. Artwork submitted in TIFF should adhere to the following resolution settings: halftones (color/grayscale): 300 dpi; line art (black and white) and mixed images (halftones with text or line art): 600 to 1200 dpi. If it is necessary to import graphics from a vector-based drawing program (e.g., Adobe Illustrator) into a raster-based program (e.g., Adobe PhotoShop) in order to produce a TIFF file, a resolution of at least 600 dpi is required for quality reproduction.
When creating your figures, use font sizes and line weights that will reproduce clearly and accurately when figures are sized to the appropriate column width. The minimum line weight is 1/2 point (thinner lines will not reproduce well). Eliminate all excess white space from the borders of each figure. Do not include figure legends or other extraneous text in a graphic file; figure legends should be provided as text, placed after the reference section in the main manuscript file. Number figures consecutively with Arabic numerals.
We also require a hard-copy printout that exactly matches the electronic version of all artwork. All figures and complex tables not transmitted in electronic form must be sent as high-quality, camera-ready hard copies.
Color figures. One piece of color art per article will be published free of charge, provided color is deemed scientifically necessary by the reviewers and the editor. Additional color figures will be charged to the author, unless color is required by the editor. Color artwork should be transmitted as CMYK color. RGB images must be converted to CMYK and all necessary color adjustments must be made prior to the transmission of the files. Authors must supply Elsevier with a color-correct CMYK printout of all color electronic art. Hard-copy submissions of color figures must be submitted on paper or flexible board due to the nature of the reproduction process.
Cover art. Authors submitting a manuscript for consideration may also submit color figures for exclusive use as cover illustrations. These figures do not need to relate to the manuscript being submitted, but should relate to the larger scope and focus of Genomics. Submit art as prints, as slides, or in electronic form (TIFF and EPS files only). A slide or electronic file should be accompanied by a print that matches it exactly. A short (one-line) legend should accompany each photograph.
Tables. Tables should be numbered consecutively with Arabic numerals (1, 2, 3, etc.) in the order in which they are referred to in the text. Type each table (double-spaced) on a separate page (not embedded in the text) with a short descriptive title typed directly above and with essential footnotes below. Table footnotes should be denoted using superscript lowercase Arabic letters (a, b, c, etc.), not symbols. Authors must submit tables in Microsoft Word format.
Proofs
Proofs will be sent to the corresponding author. Upon acceptance, the manuscript will be edited according to the style of the journal, and proofs should be reviewed carefully. Please be sure to answer all author queries. To avoid delay in publication, only necessary changes should be made, and proof corrections should be returned within 2 business days. Failure to do so will result in publication delays. Authors will be charged for alterations that exceed 10% of the total cost of composition.
Sharing information and materials
It is expected that all new biological or other reagents described in papers published in Genomics will be made available freely to all qualified members of the scientific community upon written request. If delays in strain or vector distribution are anticipated, or if these are available from sources other than the author(s), this must be indicated and, if the editor thinks it necessary, explained.
Submission of data to databases
The editorial policy of Genomics is to require the use of databases. Deposit of data in the appropriate database(s) is a condition of publication. New nucleotide data must be submitted and deposited in the DDBJ/EMBL/GenBank databases and an accession number obtained before the paper can be accepted for publication. Submission to any one of the three collaborating databanks is sufficient to ensure data entry in all. The accession number should be included in the manuscript as a footnote on the title page: "Sequence data from this article have been deposited with the DDBJ/EMBL/GenBank Data Libraries under Accession No. ...." If requested, the database will withhold release of data until publication. The most convenient method for submitting sequence data is by the World Wide Web:
DDBJ via SAKURA, http://sakura.ddbj.nig.ac.jp/
EMBL via WEBIN, http://www.ebi.ac.uk/embl/Submission/webin.html
GenBank via BankIt, http://www.ncbi.nlm.nih.gov/BankIt/
Stand-alone submission tool Sequin, http://www.ncbi.nlm.nih.gov/Sequin/
Mouse Genome Informatics, http://www.informatics.jax.org/mgihome/
For special types of submissions (for example, genomes, bulk submissions), additional submission protocols are available from the above sites. Database contact information:
DDBJ:
Center for Information Biology and DNA Data Bank of Japan
National Institute of Genetics
1111 Yata
Mishima, Shizuoka 411-8540, Japan
Telephone: 81 55981 6853; Fax: 81 55981 6849
E-mail: ddbj@ddbj.nig.ac.jp
Web URL: http://www.ddbj.nig.ac.jp/
EMBL
EMBL Nucleotide Sequence Submissions
European Bioinformatics Institute
Wellcome Trust Genome Campus
Hinxton, Cambridge CB10 1SD, UK
Telephone: 44 1223 494499; Fax: 44 1223 494472
E-mail: datasubs@ebi.ac.uk
Web URL: http://www.ebi.ac.uk
GenBank
National Center for Biotechnology Information
National Library of Medicine
Building 38A, Room 8N-802
Bethesda, MD 20894, USA
Telephone: (301) 496-2475; Fax: (301) 480-9241
E-mail: info@ncbi.nlm.nih.gov
Web URL: http://www.ncbi.nlm.nih.gov
Editorial Board
Editor-in-Chief:
M.S. Boguski
Founding Editor:
V.A. McKusick
F.H Ruddle
Associate Editors:
S.E. Antonarakis
P. Avner
S.D.M. Brown
P.M. Conneally
W.N. Frankel
J.L. Haines
R. Hardison
C.A. Kozak
J.R. Lupski
A.P. Monaco
S. L. Naylor
R.H. Reeves
T.B. Shows
L.-C. Tsui
C. Turc-Carel
R.K. Wilson
Advisory Board:
F.H. Ruddle, Chairman
Sir. W. Bodmer
S. Brenner
G.F. Cahill, Jr.
J. Dausset
J.L. Goldstein
L.E. Hood
E.S. Lander
L. Philipson
C.R. Scriver
J.D. Watson
Editorial Board:
D. Botstein
A. Bowcock
J.L. Breslow
S.A. Camper
L.L. Cavalli-Sforza
W.K. Cavenee
F.S. Collins
K.E. Davies
M.T. Davisson
A. de la Chapelle
P. D'Eustachio
H.C. Dietz
G. Duyk
J.H. Edwards
B.S. Emanuel
M.A. Ferguson-Smith
K.-H. Grzeschik
J.-L. Guenet
T. Honjo
M.W. Hunkapiller
A.J. Jeffreys
B.J. Keats
L.M. Kunkel
E. Lai
J.B. Lawrence
M.M. LeBeau
M.F. Lyon
J.D. McPherson
T.K. Mohandas
H.W. Mohrenweiser
M. Olson
J. Ott
M.A. Pericak-Vance
J.A. Phillips III
A. Rich
J.D. Rowley
P. Scambler
D. Schlessinger
A.F. Scott
N. Shimizu
J.M. Sikela
D. Soll
J.M. Trent
A. Ullrich
A. Wada
M.S. Waterman
R.T. Williamson
S.L.C. Woo
R.W. Worton
Nomenclature Editor:
S. Povey
|
刊名字顺( Alphabetical List of Journals):
返回页首 